Chat with Filing

Ask questions about this document

Please log in or register to use the chat feature. Please register first.

DIRS - PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 540 shares in PharmaSGP Holding SE in a delisting tender offer by the reporting date of the announcement published on July 21, 2025, pursuant to

Company: PharmaSGP Holding SE Date: 2025-07-23 Language: English Register to download

Loading document preview...

Document Preview Not Available

The file type (.html) cannot be displayed directly here.

Open Original File

Error loading document preview. Please try the 'Open Original File' link.

You're One Click Away From The Full Filing

Instantly access this document—and 2.8M more—for free. Select your preferred method:

Continue with Google Continue with Microsoft Continue with Facebook Continue with Amazon

 News Details 

Directors’ Dealings | 23 July 2025 17:15

#   

PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 540 shares in PharmaSGP Holding SE in a delisting tender offer by the reporting date of the announcement published on July 21, 2025, pursuant to Section 23 (1) No. 1 of the German Securities Acquisition and Takeover Act (WpÜG), i.e. by 6:00 p.m. CEST on July 18, 2025

  

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them  

  

23.07.2025 / 17:15 CET/CEST  

The issuer is solely responsible for the content of this announcement.  

  

- - -

**1\. Details of the person discharging managerial responsibilities / person closely associated**  

  

a) Name  

|     |     |
| --- | --- |
| Name and legal form: | FUTRUE GmbH |

  

**2\. Reason for the notification**  

  

a) Position / status  

|     |     |
| --- | --- |
| Person closely associated with: |     |
| Title: | Dr. |
| First name: | Clemens |
| Last name(s): | Fischer |
| Position: | Member of the administrative or supervisory body |

  

b) Initial notification  

  

**3\. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor**  

  

a) Name  

PharmaSGP Holding SE  

b) LEI  

3912005CZ12PVVCIPT91  

**4\. Details of the transaction(s)**  

  

a) Description of the financial instrument, type of instrument, identification code  

|     |     |
| --- | --- |
| Type: | Share |
| ISIN: | DE000A2P4LJ5 |

  

b) Nature of the transaction  

Tender of a total of 540 shares in PharmaSGP Holding SE in a delisting tender offer by the reporting date of the announcement published on July 21, 2025, pursuant to Section 23 (1) No. 1 of the German Securities Acquisition and Takeover Act (WpÜG), i.e. by 6:00 p.m. CEST on July 18, 2025  

c) Price(s) and volume(s)  

|     |     |
| --- | --- |
| Price(s) | Volume(s) |
| 28.00 EUR | 15,120.00 EUR |

  

d) Aggregated information  

|     |     |
| --- | --- |
| Price | Aggregated volume |
| 28.00 EUR | 15,120.00 EUR |

  

e) Date of the transaction  

19/07/2025; UTC+2  

f) Place of the transaction  

Outside a trading venue  

  

- - -

23.07.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.  

Archive at www.eqs-news.com  

- - -

|     |     |
| --- | --- |
| Language: | English |
| Company: | PharmaSGP Holding SE |
|     | Lochhamer Schlag 1 |
|     | 82166 Gräfelfing |
|     | Germany |
| Internet: | https://pharmasgp.com |

  

|     |     |
| --- | --- |
|     |     |
| End of News | EQS News Service |

- - -

99828  23.07.2025 CET/CEST

![](https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=2173000&application_name=news&site_id=airport_aws~~~7cc68db1-74de-43c8-af69-2ae0a97efdc3)

Unlock Europe's Largest Financial Database—Free

Get instant access to over 2.8M filings from 8,970 companies across 44 markets. No cost. No hassle. Just results.

Save hours with instant data access
Trusted by leading financial institutions
Free forever—no strings attached

Or sign up with

Google Microsoft

Or log in with

Google Microsoft

This premium feature is designed for professionals. Upgrade your plan to gain immediate access and enhance your research capabilities.

Upgrade Now